This is a routine conference participation announcement with no material news. Monitor the conference webcast on June 3 for any pipeline updates or commentary, but no immediate trading catalyst is present.
Price Chart
Executive Summary
Eupraxia Pharmaceuticals filed a 6-K announcing management's participation in the Jefferies Global Healthcare Conference on June 3-4, 2026. The filing contains no new clinical data, financial results, or material corporate developments — it is a routine investor conference announcement.
Key Facts
- Eupraxia management will present at the Jefferies Global Healthcare Conference on June 3, 2026, from 5:30-6:00 PM ET.
- 1x1 investor meetings are scheduled for June 3 and 4, 2026.
- The filing includes no new clinical data, financial guidance, or material business updates.
- The company is a clinical-stage biotech with EP-104GI in Phase 1b/2 (RESOLVE trial for EoE) and a completed Phase 2b (SPRINGBOARD) for knee osteoarthritis pain.
Financial Impact
No financial figures disclosed in the filing.
Risk Factors
- No new clinical data or financial updates — stock may drift on sector sentiment.
- Conference participation alone rarely moves stock price without accompanying data or guidance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-003762 |
| Exhibit: exh_991.htm | 0001171843-26-003762 |
| Document: 0001171843-26-003762-index-headers.html | 0001171843-26-003762 |
| Document: 0001171843-26-003762-index.html | 0001171843-26-003762 |
| Document: 0001171843-26-003762.txt | 0001171843-26-003762 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 6-K | $7.59 | awaiting T+5 | — | $6.85 (−9.75%) |
Oct 15, 2026 11d ago | 6-K | $6.77 $7.59 | ▲ +12.11% | ▲ +13.13% | $6.85 (+1.18%) |
Oct 9, 2026 17d ago | 6-K | $7.46 $6.62 | ▼ −11.26% | ▼ −9.29% | $6.85 (−8.18%) |
Sep 30, 2026 26d ago | 6-K | $9.10 $7.78 | ▼ −14.51% | ▼ −16.42% | $6.85 (−24.73%) |
Sep 30, 2026 26d ago | Press Release | $9.10 $7.78 | ▼ −14.51% | ▼ −16.42% | $6.85 (−24.73%) |
Aug 25, 2026 8w ago | EFFECT | $7.42 $6.34 | ▲ +14.56% | ▲ +14.02% | $6.85 (+7.68%) |
Aug 13, 2026 10w ago | 6-K | $6.67 $6.76 | ▲ +1.35% | ▲ +3.31% | $6.85 (+2.70%) |
Aug 11, 2026 10w ago | Press Release | $6.48 $7.01 | ▲ +8.18% | ▲ +8.62% | $6.85 (+5.71%) |
Jul 15, 2026 14w ago | 6-K | $6.52 $6.42 | ▼ −1.53% | ▼ −0.55% | $6.85 (+5.06%) |
Jun 19, 2026 18w ago | Press Release | $6.64 $6.60 | ▼ −0.60% | ▲ +1.47% | $6.85 (+3.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers